LENTIBONE Trademark

Trademark Overview


On Monday, June 20, 2022, a trademark application was filed for LENTIBONE with the United States Patent and Trademark Office. The USPTO has given the LENTIBONE trademark a serial number of 79348684. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Jiangsu GenScript Probio Biotech Co., Ltd.. The LENTIBONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Technological research in the field of gene synthesis; research and development of new products for others; scientific laboratory services; biochemical research; biological research; biomedical research services; pharmaceutical research services; bacteriological research; structural and functional analysis of genomes; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; development of pharmaceutical preparations and medicines; testing of pharmaceuticals
lentibone

General Information


Serial Number79348684
Word MarkLENTIBONE
Filing DateMonday, June 20, 2022
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7129106
Registration DateTuesday, August 8, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesTechnological research in the field of gene synthesis; research and development of new products for others; scientific laboratory services; biochemical research; biological research; biomedical research services; pharmaceutical research services; bacteriological research; structural and functional analysis of genomes; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; development of pharmaceutical preparations and medicines; testing of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJiangsu GenScript Probio Biotech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameJiangsu GenScript Probio Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameJiangsu GenScript Probio Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Sunday, October 15, 2023NOTIFICATION PROCESSED BY IB
Monday, September 18, 2023GENERIC MADRID TRANSACTION SENT TO IB
Monday, September 18, 2023GENERIC MADRID TRANSACTION CREATED
Thursday, September 7, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 3, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 3, 2023NOTICE OF PUBLICATION
Tuesday, April 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 30, 2023ASSIGNED TO EXAMINER
Tuesday, January 10, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Monday, October 24, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Friday, September 30, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 13, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 1, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB